• a
  • a
  • a
  • Adjust text size

subtype 2

Subtype 2 Rosacea Common in Tunisia

An analysis of hospital data in Tunisia found that subtype 2 (papulopustular) rosacea, characterized by redness with bumps and pimples, was the most commonly diagnosed form of rosacea in this Arab North African nation.1

Effective Options Are Available for Treating Rosacea Inflammation

While some signs and symptoms of rosacea can be challenging to control, effective medical therapies have been extensively studied and approved for the treatment of the bumps and pimples of subtype 2 (papulopustular) rosacea, according to the standard management options for rosacea recently published by the National Rosacea Society.1

Study Finds Allergy-Like Reaction May Trigger Bumps and Pimples

The bumps (papules) and pimples (pustules) of rosacea, a widespread facial disorder affecting an estimated 14 million Americans, in some instances may be the result of an allergy-like reaction to environmental and emotional triggers, according to new study results presented at the National Rosacea Society (NRS) research workshop during the annual meeting of the Society for Investigative Dermatology. The seventh annual NRS workshop was attended by more than 130 medical scientists from around the world.

NRS-Funded Studies Shine Light on Potential New Treatment Advances

Medical scientists reported key results of ongoing research on potential causes of rosacea during the eighth annual rosacea research workshop, sponsored by the National Rosacea Society (NRS). The workshop was conducted during the annual meeting of the Society for Investigative Dermatology, and was attended by more than 100 medical researchers from around the world.

New Studies Show High Incidence of Rosacea and Possible New Causes

The incidence of rosacea may be higher than widely believed, according to a preliminary study presented at the recent rosacea research workshop, sponsored by the National Rosacea Society (NRS) during the annual Society for Investigative Dermatology meeting. In addition, an ongoing Irish study found similar prevalence rates of subtype 2 (papulopustular) rosacea in both indoor and outdoor workers.

New Research Grants Awarded to Advance Knowledge of Rosacea

Five new studies of rosacea have been awarded funding as part of the National Rosacea Society's research grants program to advance scientific and medical understanding of this widespread but poorly understood facial disorder, estimated to affect 14 million Americans.

Subscribe to RSS - subtype 2

Contact Us

Phone:
1-888-NO-BLUSH
Email:
rosaceas@aol.com
National Rosacea Society
196 James St.
Barrington, IL 60010

Our Mission

The National Rosacea Society is a 501(c)(3) nonprofit organization whose mission is to improve the lives of people with rosacea by raising awareness, providing public health information and supporting medical research on this widespread but little-known disorder. The information the Society provides should not be considered medical advice, nor is it intended to replace

consultation with a qualified physician. The Society does not evaluate, endorse or recommend any particular medications, products, equipment or treatments. Rosacea may vary substantially from one patient to another, and treatment must be tailored by a physician for each individual case. For more information, visit About Us.